Results 131 to 140 of about 5,182 (259)
The legacy of a gentleman scientist: Pierre Hainaut. [PDF]
Arnoult C +14 more
europepmc +1 more source
Multimetal Prussian blue analogues (PBAs) are converted by low‐temperature Ar annealing into a cavity/CN‐vacancy architecture that triggers in situ Ni exsolution, creating dense Ni‐PBA interfacial motifs. These motifs optimize water dissociation and H* adsorption in alkaline media, delivering markedly accelerated HER kinetics and long‐term stability ...
Shiqi Wang +5 more
wiley +1 more source
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally. [PDF]
Sharma A +7 more
europepmc +1 more source
ROS‐Targeted Nanomotor Therapy in OA: Cartilage Protection and Pain Relief
ROS‐responsive NM@MET nanomotors utilize elevated ROS in osteoarthritic joints to promote deep penetration into cartilage and synovium and enable sustained metformin release. By scavenging ROS, regulating NRF2/KEAP1 signaling, protecting chondrocytes, suppressing synovial inflammation, and attenuating nociceptive signaling, NM@MET alleviates pain and ...
Meng Zheng +19 more
wiley +1 more source
Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]
Wu C +10 more
europepmc +1 more source
Safe and precise bioorthogonal therapy of tumors was achieved by an ultrasound‐responsive heterostructured nanoreactor with on‐demand catalytic activity. Under piezoelectric catalysis, the system undergoes reversible Pd2+/Pd0 redox cycling, concurrently enabling spatiotemporally controlled prodrug activation and self‐terminating catalytic dose ...
Daqing Xia +9 more
wiley +1 more source
Majestic palm trees: tropical nature and imagination in the context of nineteenth century European imperialism. [PDF]
Far AE.
europepmc +1 more source
Controlled electrochemical reconstruction creates a crystalline–amorphous CuNi nanotube that unifies catalytic activity and durability for alkaline oxygen evolution. The conductive metallic core and active amorphous oxide shell work synergistically to deliver low overpotential and exceptional stability exceeding 1000 h, offering a new strategy for ...
Shi‐Yu Zhu +8 more
wiley +1 more source
Efficacy and safety of obinutuzumab in active lupus nephritis. [PDF]
Ene CD, Bruchfeld A.
europepmc +1 more source

